Evidence mapPaperPMID 41497103Full record

ReviewAnnals of medicine and surgery (2012)2026

Late-stage leukemias in aging populations: a public health call for integrated and personalized care models.

Emmanuel Ifeanyi Obeagu

Abstract readReview
In one paragraph

Review in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emmanuel Ifeanyi ObeaguDepartment of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe.ORCID https://orcid.org/0000-0002-4538-0161

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Late-stage leukemias in older adults present a complex interplay of adverse disease biology, age-related vulnerabilities, and health care system challenges. Aging populations face unique clinical and public health burdens, including frailty, comorbidities, and limited access to specialized care, which complicate standard leukemia management. This narrative review synthesizes current evidence on late-stage acute and chronic leukemias in aging populations, highlighting age-specific biological features, therapeutic options, supportive-care considerations, and integrated care strategies. A structured literature search of PubMed, Scopus, Web of Science, and Google Scholar (2000-2025) was conducted using key terms including "

Indexed as

aging populationintegrated carelate-stage leukemiapersonalized medicinepublic health

Identifiers

PMID41497103
PMCPMC12768214

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.